1. |
Fukui T, Nakayama S, Shimatani M, et al. Endoscopic biliary plastic stenting and successful intentional stent retrieval in a benign biliary stricture with mural spherical calcification and porcelain gallbladder. Intern Med, 2009, 48(10): 809-813.
|
2. |
李富宇, 李宁, 蒋力生, 等.浅谈慢性增生性胆管炎在肝内胆管结石防治中的意义.中华肝胆外科杂志, 2008, 14(4): 225-228.
|
3. |
胡冰.规范胆管良性狭窄的内镜治疗.中华消化内镜杂志, 2009, 26(5): 231-233.
|
4. |
Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol, 2008, 214(2): 199-210.
|
5. |
Wrana JL, Attisano L, Cárcamo J, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell, 1992, 71(6): 1003-1014.
|
6. |
Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 113(6): 685-700.
|
7. |
Chawla A, Repa JJ, Evans RM, et al. Nuclear receptors and lipid physiology: opening the X-files. Science, 2001, 294(5548): 1866-1870.
|
8. |
Sonoda J, Pei L, Evans RM. Nuclear receptors: decoding metabolic disease. Febs Lett, 2008, 582(1): 2-9.
|
9. |
Zhao CY, Chen W, Yang L, et al. PPAR gamma agonists prevent TGFβ1 Smad3-signaling in human hepatic stellate cells. Biochem Biophys Res Commun, 2006, 350(2): 385-391.
|
10. |
Zou R, Xu G, Liu XC, et al. PPARy agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis. Acta Pharmacol Sin, 2010, 31(1): 43-50.
|
11. |
司徒镇强, 吴军正.细胞培养.第2版.西安:世界图书出版公司, 1996: 69-71.
|
12. |
Chandra V, Huang P, Hamuro Y, et al. Structure of the intact PPAR-γ-RXR-nuclear receptor complex on DNA. Nature, 2008, 456(7220): 350-356.
|
13. |
Ferguson HE, Kulkarni A, Lehmann GM, et al. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. Am J Resp Cell Mol, 2009, 41(6): 722-730.
|
14. |
Ghosh AK, Bhattacharyya S, Lakos G, et al. Disruption of transfor-ming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum, 2004, 50(4): 1305-1318.
|
15. |
Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ). J Biol Chem, 1995, 270(22): 12953-12956.
|
16. |
Straus DS, Pascual G, Li M, et al.15-deoxy-delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA, 2000, 97(9): 4844-4849.
|
17. |
Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169(3): 453-459.
|
18. |
Burgess HA, Daugherty LE, Thatcher TH, et al. PPARγagonists inhibit TGF-βinduced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol-Lung C, 2005, 288(6): L1146-L1153.
|
19. |
Shi-wen X, Pennington D, Holmes A, et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res, 2000, 259(1): 213-224.
|
20. |
Shimo T, Nakanishi T, Nishida T, et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem, 1999, 126(1): 137-145.
|
21. |
Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev, 1997, 8(3): 171-179.
|
22. |
Mori T, Kawara S, Shinozaki M, et al. Role and interaction of conne-ctive tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol, 1999, 181(1): 153-159.
|
23. |
Shi-wen X, Stanton LA, Kennedy L, et al. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem, 2006, 281(16): 10715-10726.
|
24. |
Liu S, Shi-wen X, Abraham DJ, et al. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum, 2011, 63(1): 239-246.
|
25. |
Ponticos M, Holmes AM, Shi-wen X, et al. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcrip-tional activation of type I collagen. Arthritis Rheum, 2009, 60(7): 2142-2155.
|